CareDx Inc
For the period ended Mar 31, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 30, 2025
CDNA$80.77-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $88,745 | $114,689 |
| Marketable securities | 142,172 | 145,964 |
| Accounts receivable | 71,485 | 64,605 |
| Inventory | 22,929 | 19,503 |
| Prepaid and other current assets | 24,908 | 7,071 |
| Total current assets | 350,239 | 351,832 |
| Property and equipment, net | 32,729 | 33,552 |
| Operating leases right-of-use assets | 26,390 | 24,340 |
| Intangible assets, net | 37,247 | 38,184 |
| Goodwill | 40,336 | 40,336 |
| Restricted cash | 550 | 585 |
| Other assets | 2,147 | 2,221 |
| Total assets | $489,638 | $491,050 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $8,072 | $7,686 |
| Accrued compensation | 14,067 | 38,333 |
| Accrued litigation settlement expense | 20,250 | — |
| Accrued and other liabilities | 42,895 | 43,352 |
| Total current liabilities | 85,284 | 89,371 |
| Deferred tax liability | 129 | 164 |
| Contingent consideration | 160 | 174 |
| Operating lease liability, less current portion | 24,072 | 22,263 |
| Other liabilities | 644 | 645 |
| Total liabilities | 110,289 | 112,617 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock: $0.001 par value; 10,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024 | — | — |
| Common stock: $0.001 par value; 100,000,000 shares authorized at March 31, 2025 and December 31, 2024; 55,462,730 and 54,771,203 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 51 | 51 |
| Additional paid-in capital | 1,022,982 | 1,013,193 |
| Accumulated other comprehensive loss | (7,089) | (8,569) |
| Accumulated deficit | (636,595) | (626,242) |
| Total stockholders’ equity | 379,349 | 378,433 |
| Total liabilities and stockholders’ equity | $489,638 | $491,050 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.